儿科指南

订阅

MedSci主页 / 所有栏目 / 儿科指南

2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议

2021-12-13 加拿大过敏及临床免疫学会 Allergy Asthma Clin Immunol

肾上腺素自动注射器

2021年12月，加拿大过敏及临床免疫学会(CSACI)发布了现有肾上腺素自动注射器过渡建议。

中文标题：

2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议

英文标题：

CSACI position statement: transition recommendations on existing epinephrine autoinjectors

发布机构：

加拿大过敏及临床免疫学会

发布日期：

2021-12-13

简要介绍：

2021年12月，加拿大过敏及临床免疫学会(CSACI)发布了现有肾上腺素自动注射器过渡建议。肾上腺素是过敏性反应的一线治疗药物，本文主要针对存在过敏风险的儿科人群，解决一下关于肾上腺素处方和给药的问题。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6ec541c0022919e2, title=2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议, enTitle=CSACI position statement: transition recommendations on existing epinephrine autoinjectors, guiderFrom=Allergy Asthma Clin Immunol, authorId=0, author=, summary=2021年12月，加拿大过敏及临床免疫学会(CSACI)发布了现有肾上腺素自动注射器过渡建议。, cover=https://img.medsci.cn/20211216/1639662662701_1608702.jpg, journalId=0, articlesId=null, associationId=1179, associationName=加拿大过敏及临床免疫学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Dec 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，加拿大过敏及临床免疫学会(CSACI)发布了现有肾上腺素自动注射器过渡建议。肾上腺素是过敏性反应的一线治疗药物，本文主要针对存在过敏风险的儿科人群，解决一下关于肾上腺素处方和给药的问题。</span></p>, tagList=[TagDto(tagId=119882, tagName=肾上腺素自动注射器)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7950, guiderKeyword=肾上腺素, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=6, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17465, appHits=41, showAppHits=0, pcHits=204, showPcHits=17423, likes=0, shares=179, comments=7, approvalStatus=1, publishedTime=Thu Dec 16 21:40:51 CST 2021, publishedTimeString=2021-12-13, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Dec 16 21:55:39 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 07:09:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议.pdf)])
2021 CSACI立场声明：现有肾上腺素自动注射器过渡建议.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1081426, encodeId=6de410814263e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:17 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081007, encodeId=7c5f108100e5f, content=好好学习，劳逸结合, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Fri Dec 17 07:32:42 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080998, encodeId=54fd1080998b4, content=叽叽叽叽, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:58:28 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080994, encodeId=83d810809942e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:57:38 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080923, encodeId=9b3510809237f, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97945592658, createdName=ms8000001102120434, createdTime=Thu Dec 16 22:52:28 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-18 微探

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1081426, encodeId=6de410814263e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:17 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081007, encodeId=7c5f108100e5f, content=好好学习，劳逸结合, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Fri Dec 17 07:32:42 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080998, encodeId=54fd1080998b4, content=叽叽叽叽, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:58:28 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080994, encodeId=83d810809942e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:57:38 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080923, encodeId=9b3510809237f, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97945592658, createdName=ms8000001102120434, createdTime=Thu Dec 16 22:52:28 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-17 微笑人参

    好好学习，劳逸结合

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1081426, encodeId=6de410814263e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:17 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081007, encodeId=7c5f108100e5f, content=好好学习，劳逸结合, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Fri Dec 17 07:32:42 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080998, encodeId=54fd1080998b4, content=叽叽叽叽, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:58:28 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080994, encodeId=83d810809942e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:57:38 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080923, encodeId=9b3510809237f, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97945592658, createdName=ms8000001102120434, createdTime=Thu Dec 16 22:52:28 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-17 微探

    叽叽叽叽

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1081426, encodeId=6de410814263e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:17 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081007, encodeId=7c5f108100e5f, content=好好学习，劳逸结合, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Fri Dec 17 07:32:42 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080998, encodeId=54fd1080998b4, content=叽叽叽叽, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:58:28 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080994, encodeId=83d810809942e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:57:38 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080923, encodeId=9b3510809237f, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97945592658, createdName=ms8000001102120434, createdTime=Thu Dec 16 22:52:28 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-17 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1081426, encodeId=6de410814263e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 18 06:54:17 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081007, encodeId=7c5f108100e5f, content=好好学习，劳逸结合, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220317/1c3b2db4747d42e88e5018b394979434/be0fcebf07344e9ab886c37c502e2f29.jpg, createdBy=6bb22051299, createdName=微笑人参, createdTime=Fri Dec 17 07:32:42 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080998, encodeId=54fd1080998b4, content=叽叽叽叽, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:58:28 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080994, encodeId=83d810809942e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Dec 17 06:57:38 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080923, encodeId=9b3510809237f, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97945592658, createdName=ms8000001102120434, createdTime=Thu Dec 16 22:52:28 CST 2021, time=2021-12-16, status=1, ipAttribution=)]
    2021-12-16 ms8000001102120434

    不错

    0